NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with Irish Pharmacist includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

ADVERTISMENT

ADVERTISMENT

Low levels of omega-3 associated with higher risk of psychosis — RCSI research

By Irish Pharmacist - 25th Jun 2021

Omega-3 fish fat capsules in the shape of a heart for the cardiovascular system of the body. View from above

New research has found that adolescents with higher levels of an omega-3 fatty acid in their blood were less likely to develop a psychotic disorder in early adulthood, suggesting that it may have a potential preventative effect of reducing the risk of psychosis. The study, led by researchers from RCSI University of Medicine and Health Sciences, was published recently in Translational Psychiatry.

Over 3,800 individuals in ‘Bristol’s Children of the 90s’ health study were assessed for psychotic disorder, depressive disorder and generalised anxiety disorder at age 17 and at age 24. During these assessments, blood samples were collected, and the researchers measured the levels of omega-6 fatty acids, which generally increase inflammation in the body, and omega-3 fatty acids, which generally reduce inflammation.

While there was little evidence that fatty acids were associated with mental disorders at age 17, the researchers found that 24-year-olds with psychotic disorder, depressive disorder and generalised anxiety disorder had higher levels of omega-6 than omega-3 fatty acids, compared to those without these disorders. The researchers also found that 24-year-olds with psychotic disorder had lower levels of DHA, an omega-3 fatty acid typically found in oily fish or dietary supplements, than 24-year-olds without psychotic disorder.

In a group of over 2,700 individuals who were tracked over time, adolescents with higher levels of DHA at age 17 were 56 per cent less likely to develop psychotic disorder seven years later at age 24. This suggests that DHA in adolescence may have a potential preventative effect of reducing the risk of psychosis in early adulthood. These results remained consistent when accounting for other factors such as sex, body mass index, tobacco smoking and socio-economic status.

“The study needs to be replicated, but if the findings are consistent, these results would suggest that enhanced dietary intake of omega-3 fatty acids among adolescents, such as through oily fish like mackerel, could prevent some people from developing psychosis in their early 20s,”  said Prof David Cotter, senior author of the study and Professor of Molecular Psychiatry at the RCSI.

“The results could also raise questions about the relationship between the development of mental health disorders and omega-6 fatty acids, which are typically found in vegetable oils.”

Dr David Mongan, RCSI PhD student and Irish Clinical Academic Training (ICAT) Fellow, analysed the data with the supervision of Prof Cotter and Prof Mary Cannon from the RCSI Department of Psychiatry. The ICAT programme is supported by the Wellcome Trust and the Health Research Board, the Health Service Executive National Doctors Training and Planning and the Health and Social Care, Research and Development Division, Northern Ireland.

“We need to do more research to learn about the mechanisms behind this effect, but it could possibly be related to reducing inflammation or decreasing inappropriate pruning of brain connections during adolescence,” said Dr Mongan.

ADVERTISMENT

Latest

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

Latest Issue

Irish Pharmacist December 2024

Irish Pharmacist December 2024

Read

OTC Autumn 2024

In this issue of OTC Update we focus on hydration, hair care, sports injuries, fatigue, and menopause…

Read

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT